A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma (Q44083946)
Jump to navigation
Jump to search
scientific article published in September 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma |
scientific article published in September 2004 |
Statements
1 reference
A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma (English)
1 reference
1 reference
Cook G
1 reference
Clark RE
1 reference
Morris TC
1 reference
Robertson M
1 reference
Lucie NP
1 reference
Paul J
1 reference
Franklin IM
1 reference
1 September 2004
1 reference
1 reference
126
1 reference
6
1 reference
792-798
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference